BioCentury
ARTICLE | Clinical News

Eryaspase: Ph IIb data

March 31, 2017 5:15 AM UTC

Top-line data from about 98 patients with progressive metastatic pancreatic cancer and low levels of asparagine synthetase (ASNS) in an open-label, French Phase IIb trial showed that second-line treat...

BCIQ Company Profiles

Erytech Pharma S.A.